Sangamo Therapeutics (0R1D.LSE) Q4 2024 Earnings

12NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.27
-0.17
-0.06
0.04

Details

Expected EPS
-0.01525
Actual EPS
0.04
Surprise EPS
0.06
Surprise Percent
+362.3%

Description

Sangamo Therapeutics (0R1D.LSE) has reported earnings of 0.04 per share for Q4 2024.

0 Comments

Share your thoughts